U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H19N3O4S.ClH
Molecular Weight 433.908
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RIVOGLITAZONE HYDROCHLORIDE

SMILES

Cl.COC1=CC2=C(C=C1)N=C(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)N2C

InChI

InChIKey=LKKAMJRUPIIUTC-UHFFFAOYSA-N
InChI=1S/C20H19N3O4S.ClH/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17;/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25);1H

HIDE SMILES / InChI

Molecular Formula C20H19N3O4S
Molecular Weight 397.448
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Rivoglitazone hydrochloride (CS-011) is a thiazolidinedione-derivative peroxisome proliferator–activated receptor (PPAR)-γ agonist. It has been developed as potential treatment in type 2 diabetes mellitus and was shown to decrease plasma glucose and triglyceride levels in a dose-dependent manner in animals. Phase II and III clinical studies have assessed the efficacy and safety of rivoglitazone hydrochloride in patients with type 2 diabetes mellitus.

Approval Year

PubMed

PubMed

TitleDatePubMed
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes.
2007 Apr
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes.
2011 Sep
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:50:31 GMT 2023
Edited
by admin
on Sat Dec 16 01:50:31 GMT 2023
Record UNII
60HQU68H8A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RIVOGLITAZONE HYDROCHLORIDE
WHO-DD  
Common Name English
CS-011 HYDROCHLORIDE
Code English
Rivoglitazone hydrochloride [WHO-DD]
Common Name English
2,4-THIAZOLIDINEDIONE, 5-((4-((6-METHOXY-1-METHYL-1H-BENZIMIDAZOL-2-YL)METHOXY)PHENYL)METHYL)-, HYDROCHLORIDE
Systematic Name English
2,4-THIAZOLIDINEDIONE, 5-((4-((6-METHOXY-1-METHYL-1H-BENZIMIDAZOL-2-YL)METHOXY)PHENYL)METHYL)-, MONOHYDROCHLORIDE
Common Name English
RIVOGLITAZONE HCL
Common Name English
2,4-THIAZOLIDINEDIONE, 5-((4-((6-METHOXY-1-METHYL-1H-BENZIMIDAZOL-2-YL)METHOXY)PHENYL)METHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
CAS
299176-11-7
Created by admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
PRIMARY
EVMPD
SUB107720
Created by admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
PRIMARY
PUBCHEM
9889104
Created by admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
PRIMARY
SMS_ID
100000141986
Created by admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
PRIMARY
FDA UNII
60HQU68H8A
Created by admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE